BioSpace News Archive

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN: FR0011341205 – the ‘‘ Company ’’) , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its half year financial results for the six-month period ended June 30, 2020. These results are represented in the condensed consolidated financial statements as at 30 June, 2020, reviewed

Columbia Care Inc. is scheduled to participate in the following virtual investor conferences in September:

Syntekabio, an AI and NGS-based drug development company, announced that their COVID-19 combination therapy candidates yielded lung pathogenicity recovery rate of 94.3%, while the Remdesivir showed recovery rate of 44.3%.

Freezing is recommended for preservation during COVID-19 but may cause stem cell products to become less viable

Quanta, Inc. today announced another virtual “Town Hall” style investor event, which will be broadcast live over the internet on September 10, 2020 at 1:30 PM ET / 10:30 AM PT.

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Int

CM Life Sciences, Inc. announced that it closed its initial public offering of 44,275,000 units at $10.00 per unit, including 5,775,000 units issued pursuant to the exercise in full by the underwriter of its over-allotment option.

Two-week programme to spark first pan-global debate on pharma’s 2020 transformations underway. Sessions will cover affordable medicines, ultra-rapid innovation, supply change resiliency, AI, Vaccine production, COVID -19, CDMO M&A, health-tech cross industry collaboration and many more.

Accessing recent memories can be difficult for individuals living with Alzheimer’s disease and other dementias, while long-term memories of personal importance often rem

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 . Karen Parkhill , executive vice president and chief financial officer of Medtronic, will answer questions about the company begin